Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;26(6):692-701.
doi: 10.1089/jwh.2016.5807. Epub 2016 Oct 6.

Women's Contraceptive Preference-Use Mismatch

Affiliations

Women's Contraceptive Preference-Use Mismatch

Katherine He et al. J Womens Health (Larchmt). 2017 Jun.

Abstract

Background: Family planning research has not adequately addressed women's preferences for different contraceptive methods and whether women's contraceptive experiences match their preferences.

Methods: Data were drawn from the Women's Healthcare Experiences and Preferences Study, an Internet survey of 1,078 women aged 18-55 randomly sampled from a national probability panel. Survey items assessed women's preferences for contraceptive methods, match between methods preferred and used, and perceived reasons for mismatch. We estimated predictors of contraceptive preference with multinomial logistic regression models.

Results: Among women at risk for pregnancy who responded with their preferred method (n = 363), hormonal methods (non-LARC [long-acting reversible contraception]) were the most preferred method (34%), followed by no method (23%) and LARC (18%). Sociodemographic differences in contraception method preferences were noted (p-values <0.05), generally with minority, married, and older women having higher rates of preferring less effective methods, compared to their counterparts. Thirty-six percent of women reported preference-use mismatch, with the majority preferring more effective methods than those they were using. Rates of match between preferred and usual methods were highest for LARC (76%), hormonal (non-LARC) (65%), and no method (65%). The most common reasons for mismatch were cost/insurance (41%), lack of perceived/actual need (34%), and method-specific preference concerns (19%).

Conclusion: While preference for effective contraception was common among this sample of women, we found substantial mismatch between preferred and usual methods, notably among women of lower socioeconomic status and women using less effective methods. Findings may have implications for patient-centered contraceptive interventions.

Keywords: contraception; health service delivery; patient preference; patient-centered; reproductive health; women's health.

PubMed Disclaimer

Conflict of interest statement

V.K.D. has received payments from the University of California, San Francisco, to provide content expertise during the development of a web-based educational program on early pregnancy failure funded by an anonymous donor (2012); has received payments for expert witness work for Bayer (2014, 2015); has received a one-time honorarium for participation in an expert advisory panel for Johnson and Johnson. (Dec. 2012); and is an UNPAID Merck Nexplanon trainer. The remaining authors report no conflicts of interest.

References

    1. Guttmacher Institute. Contraceptive Use in the United States. New York, NY: Guttmacher Institute, 2014
    1. Guttmacher Institute. Unintended pregnancy in the United States. New York, NY: Guttmacher Institute, 2015
    1. Tonkelaar D den, Oddens BJ. Factors influencing women's satisfaction with birth control methods. Eur J Contracept Reprod Health Care 2001;6:153–158 - PubMed
    1. Urdl W, Apter D, Alperstein A, et al. . Contraceptive efficacy, compliance and beyond: Factors related to satisfaction with once-weekly transdermal compared with oral contraception. Eur J Obstet Gynecol Reprod Biol 2005;121:202–210 - PubMed
    1. Peipert JF, Zhao Q, Allsworth JE, et al. . Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011;117:1105–1113 - PMC - PubMed

Substances

LinkOut - more resources